Full-Time

AI Research Scientist

Multiple Teams

Posted on 8/13/2025

Prima Mente

Prima Mente

11-50 employees

AI-driven neuroscience research for brain health

No salary listed

London, UK + 1 more

More locations: San Francisco, CA, USA

Hybrid

Preference for in-person work as much as possible; remote work is possible during the interview process.

Category
AI & Machine Learning (2)
,
Required Skills
LLM
Python
Tensorflow
Pytorch
Machine Learning
Reinforcement Learning
Requirements
  • Experience of leading and building highly collaborative research teams.
  • High agency with the ability to jump on any task as needed.
  • Hands on end-to-end development of high impact publications that use ML methodologies to solve biological problems.
  • Proven track record developing state-of-the-art ML models, ideally including transformers, diffusion models, or multimodal architectures.
  • Experience applying ML to large multimodal biological datasets (genomics, transcriptomics, epigenomics, proteomics, single-cell data).
  • Exceptional coding skills (Python, PyTorch, JAX, TensorFlow) and familiarity with scalable training frameworks.
  • Experience managing large-scale distributed training across GPUs/TPUs.
  • Background in generative AI, large language models, mechanistic interpretability, or reinforcement learning.
Responsibilities
  • Drive foundational research in ML for biological problems, setting ambitious agendas and leading their execution.
  • Conceptualize and develop novel foundation models, scaling them across massive, complex biological datasets.
  • Lead high-impact experiments, effectively navigating signal-to-noise in large-scale biological data.
  • Collaborate closely with interdisciplinary teams, bridging AI research, computational biology, and experimental scientists.
  • Publish influential research in leading journals and conferences, establishing thought leadership in BioAI.
  • Mentor researchers, building a vibrant, collaborative, and scientifically rigorous culture.

Prima Mente combines AI with neuroscience to study the human brain. It generates its own biological datasets and builds advanced AI models to translate discoveries into clinical and research applications, focusing on understanding brain biology and developing treatments for neurological conditions. The company uses a multidisciplinary team and a flat, collaborative culture to tackle complex problems with multi-omics and multi-modal models, sharing findings through influential publications. Its goal is to protect against neurological diseases and improve cognitive health at scale, aligning with global health priorities (SDG 3). Compared with others, Prima Mente differentiates itself through in-house data generation, a strong emphasis on neurobiology and AI integration, and a collaborative, fast-paced environment aimed at delivering real patient impact.

Company Size

11-50

Company Stage

N/A

Total Funding

N/A

Headquarters

London, United Kingdom

Founded

2022

Simplify Jobs

Simplify's Take

What believers are saying

  • Pleiades achieves 0.89 accuracy detecting Alzheimer's from blood.
  • $1M Alzheimer's AI Prize win boosts credibility and partnerships.
  • 1,000-patient study launches next month with NHS SANDBOX pilot.

What critics are saying

  • Biomni-AD's superior AI erodes PARTHENON's lead within 6-12 months.
  • NVIDIA's GPU shift obsoletes Pleiades, halting pilots in 12-24 months.
  • 48-person team fails scaling proteomics, delaying 2026 generalizability.

What makes Prima Mente unique

  • Prima Mente integrates AI with neuroscience via Pleiades epigenome model.
  • PARTHENON virtual lab compresses weeks of experiments into minutes.
  • Multi-omics wet lab generates high-throughput data for Alzheimer's biomarkers.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Growth Opportunities

Company News

PR Newswire
Mar 23rd, 2026
Alzheimer's research AI prize doubles to $2M as two teams win $1M each

The Alzheimer's Disease Data Initiative has doubled its prize competition, awarding $1 million each to two winners — Biomni-AD and Prima Mente — in the Alzheimer's Insights AI Prize. The competition, backed by Bill Gates, sought agentic AI solutions to accelerate Alzheimer's and dementia research. Launched in August 2025, the prize drew over 180 submissions. Biomni-AD developed an AI "co-scientist" that performs time-consuming research tasks in minutes with high accuracy. Prima Mente created PARTHENON, a virtual laboratory platform that compresses weeks of experimental work into minutes. Both solutions will be made freely available to researchers worldwide through the AD Data Initiative's platform. With Alzheimer's projected to affect 152 million people by 2050, the competition reflects urgent demand for innovative approaches to tackle fragmented research data.

INACTIVE